Home Financial Assets Torrent Pharma’s Massive Rs 12,500-Crore Bond Issuance Plan Approved, ETPharma
Financial Assets

Torrent Pharma’s Massive Rs 12,500-Crore Bond Issuance Plan Approved, ETPharma

Share


New Delhi: Torrent Pharma’s Securities Transfer and Stakeholders Relationship Committee has approved the issuance of, Redeemable Non-Convertible Debentures (NCDs) to raise Rs 12,500 Crores ( in one or more tranches on private placement basis.

In a stock exchange filing, the company stated to issue NCDs of face value Rs 1,00,000 each, aggregating up to Rs 12,500 crore, which will be listed on the Wholesale Debt Market segment of the National Stock Exchange (NSE).

The company will disclose details on tenure, allotment and maturity at the time of allotment, it added.

The bonds will be backed by the funds raised and select trademarks, providing 1.1x security cover.

Notably, Torrent Pharma is in the process of acquiring a controlling stake in J.B. Chemicals & Pharmaceuticals in two phases—first, a 46.39 per cent equity stake for Rs 11,917 crore, followed by the acquisition of 26% of shares from public shareholders through an open offer at Rs 1,639.18 per share.

  • Published On Jan 5, 2026 at 05:59 PM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

All about ETPharma industry right on your smartphone!






Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

MiniMax Announces First Half 2026 Financial Results

HONG KONG, Aug. 26, 2026 /PRNewswire/ — MiniMax Group Inc. ("MiniMax" or the...

FASB Proposes Cash Equivalents Guidance for Stablecoins

Subscribe to Take Into Account knowledge hub   Breaking it down Background...

Small-cap fund stress test: Schemes with greater midcap exposure fare better on liquidity

AMFI's small-cap fund stress test data for July 2026 reveals an interesting...

Pantheon International (LSE:PIN): What Comes Next?

Highlights Pantheon expands commitments across several private equity strategies. Technology, defence and...